Concepedia

Norbert Grząśko

NG

Statistics

Publications

30

Citations

2.1K

H-Index

18

Active since

2006

Affiliations

Medical University of Lublin(Current)

Medical University of Silesia

Wroclaw Medical University

Jagiellonian University

Medical University of Warsaw

Norbert Grząśko is an author at Medical University of Lublin specializing in medicine, hematologic malignancy therapy, and multiple myeloma.

ORCID

Publications per year

2006–2025

30

Publications

30

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Philippe Moreau, Tamás Masszi, Norbert Grząśko et al. · New England Journal of Medicine · 2016 · 1.1K citations · Full text

, , +14

Central nervous system involvement by multiple myeloma: A multi‐institutional retrospective study of 172 patients in daily clinical practice

Artur Jurczyszyn, Norbert Grząśko, Alessandro Gozzetti et al. · American Journal of Hematology · 2016 · 141 citations · Full text

, , +14

Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Paul G. Richardson, Shaji Kumar, Tamás Masszi et al. · Journal of Clinical Oncology · 2021 · 99 citations · Full text

, , +14

Ixazomib, an Investigational Oral Proteasome Inhibitor (PI), in Combination with Lenalidomide and Dexamethasone (IRd), Significantly Extends Progression-Free Survival (PFS) for Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): The Phase 3 Tourmaline-MM1 Study (NCT01564537)

Philippe Moreau, Tamás Masszi, Norbert Grząśko et al. · Blood · 2015 · 69 citations

, , +15

Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy

Dominik Dytfeld, Magdalena Łuczak, Tomasz Wróbel et al. · Oncotarget · 2016 · 68 citations · Full text

, , +17

1–5 of 30